Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the following investor conferences. UBS Global Healthcare ...

Selected Highlights Third quarter Operating EBITDA* of negative $28.1 million (net loss of $80.8 million), including a non-cash inventory impairment of $20.4 million, compared to positive $50.5 ...

Utilizing its existing ~1,300-square-foot garage and ~10,000-square-foot barn at their property at 357 County Highway 9, ...